Integra LifeSciences Holdings Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 836,214 830,871 780,078 732,068
Cost of Revenue 334,085 314,427 299,150 268,188
Gross Profit 502,129 516,444 480,928 463,880
Operating Expenses
Research and Development 52,088 51,012 51,451 48,114
Sales, General and Admin. 394,250 373,114 358,132 305,055
Non-Recurring Items 46,738 - - -
Other 12,697 18,536 16,433 12,017
Operating Income (3,644) 73,782 54,912 98,694
Income From Continuing Operations
Add'l Income/Expense Items (1,358) 484 1,222 1,776
Earnings Before Interest and Tax (5,002) 74,266 56,134 100,470
Interest Expense 19,788 22,237 27,640 18,356
Earnings Before Tax (24,790) 52,029 28,494 82,114
Income Tax (7,813) 10,825 505 16,445
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (16,977) 41,204 27,989 65,669
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (16,977) 41,204 27,989 65,669
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (16,977) 41,204 27,989 65,669